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??????????????? ??????? ??????? ???. ??????? PICP ?????????? ? ?????? ???????????????? ???????.
???????????? PICP ???? ?????????? ???? ? ?????? ? ?? (132,3 (81,3-216,8) ??/??) ?? ????????? ? ??????-
????? ????????? ?????? (93,2 (64,7-133) ??/??) (?=0,0068). ??????????? ?? ?? ?????? ?? ??????? PICP 
(?=0,58). ? 16 ????????? ??? ???????????? ?????????????? ????????? ??????????????? ??????-?????, ???
????????????????? ? ??????? ??????? ???. ???????????? PICP ? ???? ??? ???? ? 2 ???? ????, ??? ?
????????? ??????? (?=0,01). ? ??????? ROC-??????? ??????????? ??????????? ????? ?????????? PICP ? ??-
??????? ??????????? ??????? ???, ?????? 170,2 ??/?? (??????? ??? ?????? 0,68±0,08; 95% ?????????????
???????? 0,61-0,74; ???????????????? 68,7%; ????????????? 69,6%). ????????? ??????????? PICP ?????
170,2 ??/?? ? ?????? ? ?? ??????????????? ? ??????? ??????? ???.
Abstract. Diagnostic accuracy of C-terminal fragment of type I procollagen in detection of hidden heart failure 
in hypertensive males. Kolesnyk M.Yu. Purpose: to estimate diagnostic accuracy of C-terminal fragment of type I 
procollagen (PICP) in hypertensive males with hidden chronic heart failure (CHF). The study included 220 men with 
uncomplicated arterial hypertension (mean age 52 (46-58) years). The control group consisted of 40 healthy men of 
similar age. Ambulatory blood pressure monitoring, transthoracic echocardiography and speckle tracking 
echocardiography was performed to all participants. All patients underwent treadmill test with post-exercise evaluation 
of left ventricular (LV) filling pressure by tissue Doppler ?/?' ratio to reveal hidden CHF. The post-exercise ?/?'?13
was considered to be pathological. PICP levels in plasma were determined by ELISA. The PICP concentration was 
significantly higher in men with hypertension (132,3 (81,3-216,8) ng/ml) as compared with healthy subjects (93.2 (64,7-
133) ng/ml) (p=0,0068). The presence of LV hypertrophy did not affect the level of PICP (p=0,58). 16 patients 
presented pathological result of diastolic stress test revealing signs of hidden heart failure. PICP concentration was 2-
fold higher in these individuals as compared with other patients (p=0.01). The ROC-analysis revealed, that optimal cut-
off point is 170.2 ng/ml for PICP to detect hidden CHF (area under curve – 0,68±0,08; 95% confidence interval – 0,61-
0,74; sensitivity – 68,7%, specificity – 69,6%). The PICP level exceeding 170,2 ng/mL testifies to hidden CHF in 
hypertensive males. 
??????????? ??????????? (??) ??????????
????? ? ???????? ?? ?????????????? ????????
?????? ????????? ???????? ????????????? (???)
[2]. ??????????? ??????????? ? ????? ???????
???????. ??????????, ?? ????????? ?????? ?? ?? ?
2025 ???? ????? 1,56 ???? ???? [9]. ?????????????
???????? ???????? ???????????????? ?????????
??????? ????????? ????????? ?’???, ??
????????? ??????????? ?? ??????? ?????????-
?????, ? ????? ????????????? ????????-
????????? ???????? ? ????????? ???????. ??
???????? ????????
??????? ???????????36
???????????? ????? ?????? ?????????? ?? ????-
???????? ????? ???????? ?????????????.
????????????? ??????????? ???????????, ??
???????????? ???? ???????? ??? ??, ? ??????-
??? ????????? ?????? ?????????? ????????
?????. ????? ? ????????????? ???????? ??????-
????????? ??????? ????????????? ?-????????????
???????? ??????????? I ???? (PICP). ????? ??-
??? ????????? ??????????? ???????? ??? ???-
?????????? ????????? ??????????? ???????????,
??? ?????? ????????? ? ???????? ??????????-
???? ?????????? ??????? ???????? ?? ???? ???-
???????? ??? ??????? ????????? [3, 4]. ? ??’????
? ??? ???????? ??????? ??????????????? ?????
??????? ? ??????????? ??????????? ???????? ??-
???????????. ??? ?? ????????????, ?? ???????,
??? ?? ?????????? ???????? ?????? ??????
????????. ?????? ????????????? ?????????? ???-
????? ??? ???????? ? ????? ??????, ??? ????-
??????? ??? ??? ????????? ????????????.
???????????? ?????-??????????????? (?????-
?????) ? ????????? ???????? ????????????? ??
??????? ???????????? ??????? ?? ?????? ?????
????? ????????? ??????? ???? ? ????????
?????????? ???????? ????????????? [8].  
????? ?????? ??????????? ????? ?????? ??-
????????????? C-????????????? ????????? ???-
???????? I ???? ? ????????? ? ?? ? ?????????
?????????? ????????? ???????? ?????????????.
????????? ?? ?????? ??????????
? ??????????? ???? ???????? 220 ????????? ?
????????????? ?? ?? ??????????? ???????. ???-
??????? ????????? ???? ?? 1-3 ???????, ????-
????? ????, ????????? ???????? ????? ?? ??-
??????? ???????? ?????????????, ????????
??????????? ????? ?? ?????? ? ?????????? ??-
?????????. ?? ????????? ?????????? ????????
????????????? ??, ?????????? «?????? ??????», 
???????? ??????? ?????, ???????? ?? ?????? ????
?????, ??????????????, ???????? ?????? 1 ???? ??
2 ???? ?? ???????????????, ???????? ????????????
??????, ??????? ?????????? ?? ??????????? ???-
????, ??????? ?????? ?? ????? 45%, ?????????
??????????? ?????????? (???) ????? 60 ??/??
?? ???????? MDRD. 
?????????? ????? ?????? 40 ?????????
???????? ?????????, ????????? ?? ?????.
???? ????????? ?????????? ?????????? ??-
???????? ?????? ? ???????????? ????????? ???-
??????? «??????????? ???????????» (????? ???
? 384 ??? 24.05.2012). ??????????? «????????»
????????????? ????? (??) ????????? ????? ? ???-
????????? ???????????. ???? ????????? ?????-
???? ??????? ?????????? ?? ?? ?????????
??????? ????-04 (Meditech, ????????).
??????????????? ??????????????? ????????-
?? ?? ??????????????? ??????? MyLab 50 (Esaote, 
??????) ? ????????????? ?????????? ??????? ??
240 (2-4 ???) ? ????????????? ? ?????????????-
??????. ????????? ???????-???????????? ??????
(???) ??, ??????? ?????????????? ?????????-
?? ?? ??????? ?????? ??. ?????????? ????
???????? ?? ? ??????????? ?? ????? ????????
???? (?????) ????????? ?? ???????? ?????-
????????? ?????????? ???????????????. ???????
?????? ?? ????????? ?? ??????? Simpson. ???
???????????? ?????????? ?? ?????????????
?????? ? ?????????????? ???????????? ?????????
??????????????? [12]. ?????????? ?????????
????????? ??? ??? ???????? ?????????? ?? (?)
?? ????? ??????????? ????????? ???? ??????????
??????? ?????????? ?????? ??????????? ???????
(?') ?? ??????????? ?????????????? ?/?'. ?? ???
?????????? ????????? ???? ?????????? ??.
??????????? ????????? ??????? ?/?' <8, ????-
???????? - >13. ???? ???????? ?/?' ??? ?
????????? 9-13, ?? ???? ?????????? ?? ???????
?????????? ?? ????????? ??????????? ?? ??/???
?????????? ??????? ??’??? ?? ?????? 34 ??/?2.
???? ????????? ????????? ?????-??????? ???-
???????????? ??? ??????????? ?????????????
???????????? ???????? ??. ??? ????? ????-
??????? ????? ?????????? ?????? ?????, ????-
????? ? ??????????? ??????? ???????? 3 ?????-
??? ??????. ????????? ??????? ????????? ?????-
???? ??????????? ? ?????? off-line ?? ?????????
??????????? ?????? X-Strain («Esaote», ??????). 
??????? ?????????? ??????????? ?????? ??
?????? ???? ?? ? ??????? ?? ????? ????????. ?
??’???? ? ???????? ???????? ?? ?????? ??????????
?????-??????? ??????????????? ??????? 145 ??-
??????? (65,9% ??? ???? ?????????? ??????).
??????????????? ???????????????? ????
?????????? ?? ???????? ?2100 ? ?????????????
??????? «Cardiosoft 6.0» (General Electric, ???)
?? ??????????? ?????????? Bruce. ?????-????
??????????? ??? ?????????? ????????? 85% ???
???????????? ?? ????? ???????????? ???????
???????? ????????? (???) ??? ??? ????? ?????
??????????? ????????? ??????????. ????????-
????? ?? ????????? ???????????? ????????? ?
???????????? ???????????? (???). ?????? ?????
?????????? ????????? ???????????? ??????
????????? ? ????????????? ????????? ?? ?????
??? ?? ????????? ?????????????? ?/?' ???????
????????? ??????????????. ?????????? ?????????
??????????? ?? ??????? ?????? ??????? ???-
????????????? ???????. ???????????? ???????
?/?'>13 [6]. 
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???????? ???????????? ?-?????????????
????????? ??????????? I ???? ????????? ????-
??? ????????????? ???????????????? ??????? ??
????????? ???????????? ?????? ???????????
????? «Uscn Life Science Inc.» (???). ??????
????? ????? ?????? ?????????? ? ???????? ?
EDTA ?? ??????? ?????????????? ?? ?????????
3000 ??/?? ???????? 10 ??????. ???????? ????-
?? ????????? ?? ???? -700?. ?????????? ??????-
?????? ??????? ??????????? ?? ????????? ?????-
??????????? ????????????? ????????? Immu-
noChem-2100 (High Technology, ???).
???????????? ?????? ????????? ?? ?????????
???????? STATISTICA 6.0 (Statsoft, C??) ??
Medcalc 11.6.0.0 (Medcalc Software, ???????).
?????? ???????????? ????????? ?????????? ????-
????????? ?? ????????? ??????-?????. ????
???????? ?????????? ?????? ? ??????? ??????????
????????????? ?? ???????????? ?????????? ???
??????? ?? ??????????????? ??????? ??????? ???
????????? ??????. ?????? ????????? ????????????
? ??????? ?????????? ??????? ?? ?????????.
?????????? ???? ????????? ?? ?????????
??’?????? ??? ?????-?????. ???????????? ???-
??? ?????????? ?? ????????? ???????? ????-
????. ??? ???????????? ?????????? ????????
(cut-off) ??? PICP ?? ??????? ??????? ???????????
??? ????????? ROC-??????. ??? ???????????
????? ???? ??????????, ??????????? ??????? ???-
?????? ?? ?<0,05.
?????????? ?? ?? ???????????
???????? ?????????????? ????????? ????-
???????? ? ??????? 1. 65% ?????????? ???? ????
??????????? ??, ? 50% ???? ??????????? ??????-
????? ?????????? ??. ????????? ???????
?????? ???? ?????????? ???? ???? ??? ????????.
74,2% ????????? ???? ???????????? ????????. ?
83,5% ?????? ???? ???????? ????????????.
? ? ? ? ? ? ?  1  
???????? ?? ????????????????? ?????????????? ?????????
???????? ????????
???, ???? 52 (46-58) 
?????????? ???????, ???? 5 (3-10) 
??????? ?????, ????????? ???? ( %) 100 (45,2%) 
?????? ???? ????, ??/?2 29 (26,5-32,2) 
????? ?????, ?? 102±11 
??????? ??????????? ??, ?? ??.??. 149 (137-160) 
??????? ???????????? ??, ?? ??.??. 95 (88-104) 
??????????????? ??????????? ??, ?? ??.??. 140 (132-150) 
??????????????? ???????????? ??, ?? ??.??. 87 (82-94) 
??? ?? MDRD, ??/??. 97 (83-109) 
??????? ?????? ???????? ?????, ?????/? 5,2 (4,9-5,9) 
????????? ??????????, ?????/? 5,8±1,19 
?????????? ??????? ?????????, ?????/? 4,1±1,1 
?????? ???????, ??????/? 367 (309-428) 
???????-???????????? ?????? ??, ?? 5,2±0,49 
??????? ?????? ??, % 69,6±6,1 
?????, ?/?2 129 (106-155) 
????????? ??????????? ?? ?? ?????? ???????????????, ????????? ???? (%) 147 (66,5%) 
????????? ???????????? ?????????? ??, ????????? ???? (%) 110 (50%) 
?/?' ?????? 7,5 (6,4-9) 
?????????? ?????????? ?????? ??, % -16,1±2,2 
?????????? ?????????? ??????????? ?????? ???? ??, ?-1 0,94 (0,88-1,03) 
?????????? ?????????? ?????? ???????????? ?????? ???? ??, ?-1 0,92 (0,8-1,1) 
???????? ????????
??????? ???????????38
PICP ??? ?????????? ????? ? ?????? ?? ??
????????? ? ??????????????? ????????? ?????-
???? ?????????? (?=0,0068) (???. 1 ?). ???? ??????
? ?????????????? ????????? ???????? 93,2 (64,7-
133) ??/?? ????????? ? 132,3 (81,3-216,8) ??/?? ?
?????????????? ?????????. ??????????? ????????
???????????? ?? ?????? ??????? ??? ??????? ?
???????????? ?? (129,4 (79,5-231,1) ??/??) ??
??? ??? (140,6 (90,7-209,4) ??/??) ???????? ??
???? (???. 1 ?). ????????? ???????????? ???-
??????? ?? ????? ?? ???????? ?? ????????????
PICP. ? ????????? ? ??????????? ???????????
???????? ?? ??? ???????? 139,7 (85,2-223,4) ??/??,
? ? ?????? ? ????????? ???????????? ???????? – 
125,5 (79,5-195) ??/?? (?=0,59).
???.1. ???????? ???????????? PICP ? ????????? ? ?? ?? ????????? ???????? ????????? (?), ? ?????????
? ???????????? ?? ?? ??? ??? (?), ? ?????? ? ???????????????????? ?/?'?13 ?? ?/?'<13 (?).  
ROC-????? PICP ? ?????? ?????????? ?????????? ??? (?)
??????????????? ????? ?? ???????? ????????
210 ????????? (95,4%). ? ????? ?????? ?????
???? ??????????????? ????? ??????????????
??????? 85% ??? ???????????? ?? ????? ???????
???????? ?????????. ?? ???????????? ??????-
?????? ?????-??????????????? ? 16 ????????? ????
??????????? ?????????? ?????????????? ?/?'>13, 
?? ???????? ??? ????????? ?????????? ????????
?????????????. ??????????? ?????????????? ????
??????? ?? ????? ?????? ???????????? ?
??????? 2. 
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? ? ? ? ? ? ?  2  
??????????? ?????????????? ?????? ?? ?? ? ??????????
?? ???????????? ???????? ????????? ?/?' ?? ??????? ????????????
???????? ????? ? ?/?’<13 ????????????????? (n=194) 
????? ? ?/?’ ?13 ?????
???????????? (n=16) ?
???, ???? 51 (46-57) 55 (51-60) 0,01 
?????????? ???????, ???? 5 (3-10) 10 (4-10) 0,11 
?????? ???? ????, ??/?2 28,7 (26,5-32,1) 30,7 (28,6-32,6) 0,18 
????? ?????, ?? 102 (94-109) 106 (100-113) 0,16 
??????? ??????????? ??, ?? ??.??. 146 (136-159) 157 (143-165) 0,06 
??????? ???????????? ??, ?? ??.??. 94 (88-103) 101 (91-110) 0,08 
??????????????? ??????????? ??, ?? ??.??. 140 (132-149) 151 (137-162) 0,07 
??????????????? ???????????? ??, ?? ??.??. 87 (82-93) 90 (81-103) 0,41 
??? ?? MDRD, ??/??. 98 (84-109) 82 (72-99) 0,01 
???, ?? 5,2±0,48 5,4±0,6 0,15 
?????, ?/?2 127 (105-148) 165 (148-208) 0,00003 
??????? ?????? ??, % 70±6,7 64±7,6 0,001 
?/?' ?????? 7,5 (6,4-8,7) 9,9 (7,1-11,3) 0,007 
???, ??. 9,1 (7,1-10,5) 7,1 (5,8-10,1) 0,08 
?????????? ?????????? ?????? ??, % -16,3±2,14 -14,6±2,6 0,017 
?????????? ?????????? ??????????? ??????
???? ??, ?-1 0,94 (0,88-1,04) 0,88 (0,76-0,95) 0,01 
?????????? ?????????? ?????? ????????????
?????? ???? ??, ?-1 0,93 (0,83-1,14) 0,75 (0,49-0,82) 0,01 
?-???????????? ????????
??????????? I ????, ??/?? 128 (80,7-191,5) 267 (121,6-557,9) 0,01 
???????? ? ???????????? ??????????? ?????
?????????? ?? ???? ???????? ?? ????? ?? ????
?????? ????? ?????????? ???????? ???????-
???????. ? ??? ???? ?????? ???????? ?????
?? ?/?' ? ????? ??????, ? ????? ???????? ???.
??? ?????? ?? ?????????? ?????????????????-
???? ?/?'?13 ???? ??????????? ???????? ?????-
?????? ?? ???????????? ?????????? ???????????
?????????? (????. 2). ?????? PICP ??? ? 2 ????
????? ? ????????? ? ???????? ?????????? ???
?? ???????????? ????????????? ?????-?????
(???. 1 B). ??? ?????????? ????????????? ???????
??????????? ?????? ??’???? ??? PICP ?? ?????
(r=0,15; p=0,017), ? ????? ?????????? ?/?' ?????
????????? ???????????? (r=0,13; p=0,04). ?? ??-
??????? ROC-??????? ???? ???????????, ??
??????????? ?????? ????????? ???? ?????????
?????????? ??? ? ???????????? PICP, ?? ??-
?????? 170,2 ??/?? (????? ??? ?????? 0,68±0,08; 
95% ???????? ???????? 0,61-0,74; ??????????
68,7%; ????????????? 69,6%). 
??????????? ?????????? ????? ??????????
?? ??? ?? ? ????????????? ?????????? ?????-
????? ???????? ??, ?? ????????? ?????????
??????????????? ???????. ??? ????????????
?????? ???????????????? ??????????? ????????
????????, ????????? I ????, ??? ??????????
?????? ???? ??????????. ?????? ???? ???? ????-
??????? ? ???????????? ?? ????????? ????????-
?????? ????? ????? SHR, ?? ??????? ?????
???????? I ???? ? ?????????? ???????? ? ??????
????? ????????? ? ??????????????? ??????
[1]. ?????????? ???????? ??????? ???????? I ??-
??, ? ???? ???? ?-????????????? ?????????,
???????? ????????? ??????????? ???????????
??????????????? ???????. PICP ???????????????
??? ???????? ??????????? ??? ??????? ????????
?????????? ?? ????????????? ? ???????? ?
???????? ????????
??????? ???????????40
???????????????? ?????????????? 1:1. ??????
??? ????? ????????? ? ??????? ???????? ?
?????????? ???????? ?????? ?? ??, ?????????
?? ????????? ?????????????????? ??????? [13]. ?
?????????? ???????????? ?? ? ????? ?????? ????
???????????, ?? ??? ?? ?????? PICP ??????????
?????, ??? ? ?????????????? ???? [11]. ???
????? ????????? ??????????? ?? ?????? ??
??????? ?? ???????? ???????. ????? ?????? PICP 
??????? ? ????????? ? ?? ?? ???????? ????????
????????????? [10]. ? ??????????? Martos P. et al. 
???? ???????????, ?? PICP ??? ????????????
???????? ? ????????? ??? ?? ?????????? ????-
???? ?????? ?? [5]. ???????? ????? ????
???????? ??? ?? ?????? ROC-??????? ? ???
?????? ????????? 220 ??/??. ?? ?????? ??????
???????????, PICP ? ????????? ? ?? ? ???????-
?????? ???????? ??? ?? ????? ??????????? ???-
????? ?????????????, ???? ?????? ??? ????-
??????? ???? ?? ???? ????????? ????????????.
???? ?????????? ? ????????? ? ?? ???? ????
???????? ? ????? ???????????? ??????? ????-
???? ?????? ???????? ???. ????????????? ??-
??? ? ?????????? ??????????? ???????????
????? PICP ?? ???? ???????????????????
????????? [7].  
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